VOICES FROM THE INDUSTRY: Life sciences patents still alive after Supreme decision
In late April, the U.S. Supreme Court decided an important case-KSR International v. Teleflex Inc.-that addressed the test for determining whether a patent is obvious and therefore invalid. As is often the case, the court’s opinion set off considerable speculation about how broadly it should be interpreted: Does it establish a broad, general principle? Is it creating a trend that patents are more likely to be found obvious in the future? Or is its significance limited to the patent in…